Taiho Oncology
NJ - PrincetonBiotechnology
Focus: Taiho Oncology is a 5,000+ employee oncology-focused biotechnology company headquartered in Princeton, NJ, specializing in small-molecule cancer therapeutics. The company generates 68% of revenue from its flagship product LONSURF, indicating a concentrated, mature commercial portfolio.
Profile data last refreshed 13h ago · AI intelligence enriched 3w ago
Employees
5000+
Open Jobs
0
About Taiho Oncology
AI assessmentNot HiringNo open roles listed right now. Follow Taiho Oncology to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$176M Part DStable
Peak10.5yr
Flagship product representing 68% of total revenue; dominant position but faces extended patent cliff exposure through 2037.
Help build intelligence for Taiho Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.